Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: VMD (Veterinary Medicines Directorate)
Meloxicam
Boehringer Ingelheim Vetmedica Gmbh
QM01AC06
Meloxicam
Oral suspension
POM-V - Prescription Only Medicine – Veterinarian
Cats, Guinea Pig
Anti Inflammatory NSAID
Authorized
2007-04-20
EMA Version September 2021- AN: 01220/2021 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Metacam 0.5 mg/ml oral suspension for cats and guinea pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: ACTIVE SUBSTANCE: Meloxicam 0.5 mg (equivalent to 0.017 mg per drop) EXCIPIENT: Sodium benzoate 1.5 mg (equivalent to 0.05 mg per drop) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension. Yellowish viscous oral suspension with a green tinge. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats and guinea pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cats: Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery. Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats. Guinea pigs: Alleviation of mild to moderate post-operative pain associated with soft tissue surgery such as male castration. 4.3 CONTRAINDICATIONS Do not use in pregnant or lactating animals. Do not use in cats suffering from gastrointestinal disorders such as irritation and EMA Version September 2021- AN: 01220/2021 Page 2 of 8 haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in cats less than 6 weeks of age. Do not use in guinea pigs less than 4 weeks of age. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity. Post-operative use in cats and guinea pigs: In case additional pain relief is required, multimodal pain therapy should be considered. Chronic musculoskeletal disorders in cats: Response to long-term therapy should be monitored at regular intervals by a veterinary surgeon. Special precautions to be take Διαβάστε το πλήρες έγγραφο